Arcus Biosciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
15.42 | 57.87 | -73.36% | 9.6 | +60.56% |
| P/S |
|
11.48 | 4.07 | 182.34% |
|
|
| P/BV |
|
2.91 | 9.39 | -69.05% |
|
|
| P/FCF |
|
-4.3 | 46.57 | -109.24% |
|
|
| Ev/Ebitda |
|
-4.22 | 17.62 | -123.93% |
|
|
| Ev/S |
|
10.49 | 4.37 | 140.07% |
|
|
| Ev/FCF |
|
-3.72 | 54.58 | -106.81% |
|
|
| E/P |
|
-0.2162 | 0.2164 | -199.9% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-248.72 | 20.15 | -1334.45% | -240.64 | +3.36% |
| ROE |
|
-66.45 | -80.86 | -17.82% |
|
|
| ROA |
|
-28.04 | 6.71 | -517.58% |
|
|
| ROIC |
|
7.17 | 15.68 | -54.26% |
|
|
| ROS |
|
-262.39 | 10.56 | -2585.93% |
|
|
| ROCE |
|
-64.72 | 18.05 | -458.53% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0378 | 2.87 | -101.32% | 0.3069 | -112.32% |
| Nеt Debt/Ebitda |
|
0.3986 | 3.69 | -89.21% |
|
|
| Debt/Ratio |
|
0.01 | 0.2643 | -96.2% |
|
|
| Debt/Equity |
|
0.0103 | 4.83 | -99.79% |
|
|
| Debt/Net Income |
|
-0.0358 | 6.45 | -100.56% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.31 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.4 | -100% | ||
| DSI |
|
0 | 0.7399 | -100% |
|
|
| Average dividend growth |
|
0 | -2.86 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.3 | -100% |
|
|
| Average percentage for payments |
|
9.43 | 77.61 | -87.84% |
|
|
| Difference from average difference in sector |
|
-1.31 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
680 | 362.86 | 87.4% | ||
| Growth impulse Ebitda in 5 years |
|
219.05 | 373.75 | -41.39% | ||
| Growth impulse Net Income in 5 years |
|
298.18 | 454.84 | -34.44% | ||
| Growth impulse FCF in 5 years |
|
337.67 | 306.17 | 10.29% | ||
| Growth impulse EPS in 5 years |
|
135.72 | 455.99 | -70.24% |
IP Score
5.19/10
